Ivax Diagnostics, Inc. (IVD) Reports Q3 Loss of $0.04, Flat Y/Y
Ivax Diagnostics, Inc. (NYSE: IVD) reported Q3 EPS of ($0.04), versus ($0.04) reported last year. Revenue for the quarter came in at $4.06 million, versus $3.95 million reported last year.
You May Also Be Interested In
- Felcor Lodging Trust, Inc. (FCH) Misses Q2 FFO by 4c
- Perficient, Inc. (PRFT) Reports In-Line Q2 EPS
- RGC Resources, Inc. (RGCO) Reports Q3 EPS of $0.06
Create E-mail Alert Related CategoriesEarnings
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!